M2
Medical 21, Inc.
SEC filingBiotechnology · Plymouth, MN
Amount raised$10Msold at filing
Total offering$20M$10M still open
Investors in the raise39count reported to the SEC
FiledAug 21, 2025first sale Feb 9, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Eric SolienExecutive Officer
Erik HermansenExecutive Officer
Chaid SchwarzExecutive Officer
Manny VillafanaExecutive Officer, Director, Promoter
Jeff VreemanExecutive Officer
Andrea SweeneyExecutive Officer
Executive officers, directors and promoters as listed on the Form D.